Nu Skin Enterprises (NYSE:NUS) Announces Earnings Results

Nu Skin Enterprises (NYSE:NUS) released its earnings results on Thursday. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.14, Zacks reports. Nu Skin Enterprises had a positive return on equity of 5.47% and a negative net margin of 5.81%. Nu Skin Enterprises updated its Q1 2025 guidance to 0.100-0.200 EPS and its FY 2025 guidance to 0.900-1.300 EPS.

Nu Skin Enterprises Trading Up 23.8 %

Shares of NYSE:NUS traded up $1.53 during midday trading on Friday, hitting $7.95. 1,931,409 shares of the stock were exchanged, compared to its average volume of 727,831. The stock has a market capitalization of $395.19 million, a price-to-earnings ratio of -3.85 and a beta of 1.17. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.20 and a current ratio of 1.93. The business’s 50-day moving average price is $6.91 and its 200 day moving average price is $7.50. Nu Skin Enterprises has a 12 month low of $5.95 and a 12 month high of $14.64.

Wall Street Analyst Weigh In

A number of research firms have issued reports on NUS. DA Davidson decreased their target price on Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th. Citigroup decreased their target price on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research report on Tuesday, October 22nd. Finally, StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Monday, November 11th.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.